Ronald L. Burkes - Concepedia

Author

Ronald L. Burkes

Also Known As

A Bezjak, Goldberg, Melvyn, R Burkes, R L Burkes, R. Burkes, R. L. Burkes, R.L. Burkes, Ronald Burkes, Ronald L Burkes, Ronald L. Burkes

143

Publications

12.2K

Citations

H-Index

Concepts

All Affiliations

Mount Sinai Hospital Princess Margaret Cancer Centre University of Toronto University Health Network Credit Valley Hospital

About

Ronald L. Burkes is an author at Mount Sinai Hospital specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	35	3.1K
2	Health Sciences	7	7	262
3	Social Sciences	3	3	1.1K
4	Public Health	1	1	23
5	Allergy	1	1	138

Ronald L. Burkes

Publications

11.7K

Citations

H-Index

Page 1

	Year	Citations
Panitumumab–FOLFOX4 Treatment and <i>RAS</i> Mutations in Colorectal Cancer Jean‐Yves Douillard, Kelly S. Oliner, Salvatore Siena, New England Journal of Medicine	2013	2.2K
Prospective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy Frances A. Shepherd, Janet Dancey, Rodryg Ramlau, Journal of Clinical Oncology	2000	2.2K
Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study Jean‐Yves Douillard, Salvatore Siena, James T. Cassidy, Journal of Clinical Oncology	2010	1.8K
Non-Hodgkin's Lymphoma in 90 Homosexual Men John L. Ziegler, Jay A. Beckstead, Paul A. Volberding, New England Journal of Medicine ImmunodeficienciesImmunologyPathologyHomosexualityQueer Theory	1984	981
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer J.-Y. Douillard, Salvatore Siena, J Cassidy, Annals of Oncology	2014	596
Trimodality Therapy With Induction Chemotherapy Followed by Extrapleural Pneumonectomy and Adjuvant High-Dose Hemithoracic Radiation for Malignant Pleural Mesothelioma Marc de Perrot, Ronald Feld, John Cho, Journal of Clinical Oncology	2009	288
Induction chemoradiation and surgical resection for non–small cell lung carcinomas of the superior sulcus: Initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) Valerie W. Rusch, Dorothy J. Giroux, Michael Kraut, Journal of Thoracic and Cardiovascular Surgery Intergroup Trial 0160Surgical OncologySuperior SulcusMedicineBronchial Neoplasm	2001	286
Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial Charles S. Fuchs, Kohei Shitara, Maria Di Bartolomeo, The Lancet Oncology First-line TherapyGastrointestinal OncologyMedicinePathologyMetastatic Gastric	2019	276
Activity of gemcitabine in patients with non-small cell lung cancer: A multicentre, extended phase II study U. Gatzemeier, Frances A. Shepherd, Thierry Le Chevalier, European Journal of Cancer MedicinePharmacologyPhase Ii StudyPharmacotherapyAnti-cancer Agent	1996	242
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial. Ronald L. Burkes, Robert J. Ginsberg, Frances A. Shepherd, Journal of Clinical Oncology	1992	192

Page 1